Biosimilars and Generic Drug Development

Biosimilars and generic drugs play a vital role in improving global access to affordable and effective medicines, making healthcare more accessible while maintaining high standards of quality, safety, and efficacy. This session focuses on the development, evaluation, and regulatory pathways of biosimilars and generic pharmaceutical products. Generic drugs are chemically identical to branded medications and are developed after the expiration of patent protection, offering cost-effective alternatives without compromising therapeutic outcomes. In contrast, biosimilars are highly similar to already approved biologic products, with no clinically meaningful differences in terms of safety, purity, and potency, although their development is more complex due to the intricate nature of biological molecules. The session will explore key aspects such as formulation development, analytical characterization, bioequivalence studies, and clinical evaluation required for approval. Regulatory requirements and guidelines governing biosimilars and generics across different regions will be discussed, highlighting the importance of demonstrating comparability and maintaining stringent quality standards. Challenges such as manufacturing variability, immunogenicity concerns, and market acceptance will also be addressed. Advances in analytical technologies and manufacturing processes are enabling more efficient development and quality assurance of these products. Additionally, the role of biosimilars and generics in reducing healthcare costs and increasing patient access to essential medicines will be emphasized. This session aims to provide comprehensive insights into the scientific, regulatory, and commercial aspects of biosimilar and generic drug development, highlighting their significance in the evolving pharmaceutical landscape and their contribution to sustainable healthcare systems.

    Related Conference of Biosimilars and Generic Drug Development

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Biosimilars and Generic Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in